Drug recall · November 30, 2016
Amoxicillin for Oral suspension recall
Why: Labeling: Label Error on Declared Strength: Some bottles miss a color coded panel where the strength of the product is typically displayed.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Amoxicillin for Oral suspension, USP 400 mg/5 mL, 100 mL (when reconstituted), Rx only, Manufactured by: Hikma Pharmaceuticals, P.O. Box 183400, Amman 11118 - Jordan, NDC 0143-9887-01
- Lots / codes
Lot #: AS1466A, Exp. Jan 2019
- Quantity
- 32,102 bottles
- Company
- West-Ward Pharmaceuticals Corp., Eatontown, NJ
- Distribution
- Nationwide
- Initiated
- November 4, 2016 · Voluntary: Firm initiated
- Classified
- November 22, 2016
- Reported
- November 30, 2016
- Ended
- June 16, 2017
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Amoxicillin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.